Chembio Diagnostics, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Chembio Diagnostics, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Chembio Diagnostics, Inc.. The Group's principal activity is to develop and manufacture rapid tests to aid in the detection of infectious diseases. The majority of revenues are generated through contract manufacture of private label pregnancy tests for regional pharmacies, drug stores and mass merchants in the United States, Europe, Canada, and Central America. The main products that are marketed and that are commercially available are three HIV Rapid Tests. The three HIV Rapid Tests are Sure CheckT82; HIV and HIV 1/2 Stat-Pak and HIV 1/2 Stat-Pak Dipstick. The products are sold to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, and medical professionals.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report